William Li
Patrimonio netto: 192 285 $ in data 31/05/2026
Patrimonio netto: 192 285 $ in data 31/05/2026
William W.
Li is the founder of The Angiogenesis Foundation, established in 1994, serving as President & Medical Director.
Current jobs include Independent Director at Ceapro, Inc. since 2014, Independent Director at Cypherpunk Technologies, Inc. since 2017, and Scientific Advisor at The Courtagen Group LLC.
Former jobs include Director at IBOD Imaging, Inc. from 2003 to 2006, Director at DOBI Medical Systems, Inc., Independent Non-Executive Director at Medicenna Therapeutics Corp.
from 2017 to 2019, Independent Director at COSCIENS Biopharma, Inc., and Director at Æterna Zentaris, Inc. Education includes undergraduate studies at Harvard College and a doctorate from the University of Pittsburgh School of Medicine.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 01/07/2026 | 168.750 ( 0,16% ) | 190 688 $ | 31/05/2026 | |
0,03% | 03/01/2025 | 799 ( 0,03% ) | 1 598 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| CEAPRO INC. | Direttore/Membro del Consiglio | 20/11/2014 |
| CYPHERPUNK TECHNOLOGIES INC. | Direttore/Membro del Consiglio | 01/01/2017 |
The Courtagen Group LLC
The Courtagen Group LLC Investment ManagersFinance Acts as an alternative investment manager | Corporate Officer/Principal | - |
The Angiogenesis Foundation
The Angiogenesis Foundation Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit organization that engages in disrupting disease through angiogenesis | Fondatore | 01/01/1994 |
| Società | Posizione | Fine |
|---|---|---|
| MEDICENNA THERAPEUTICS CORP. | Direttore/Membro del Consiglio | 24/09/2019 |
IBOD Imaging, Inc.
IBOD Imaging, Inc. Medical SpecialtiesHealth Technology Develops devices for diagnosing breast cancer | Direttore/Membro del Consiglio | 26/06/2006 |
Æterna Zentaris, Inc.
Æterna Zentaris, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products for diagnosis of adult growth hormone deficiency | Direttore/Membro del Consiglio | - |
DOBI Medical Systems, Inc.
DOBI Medical Systems, Inc. Medical SpecialtiesHealth Technology Develops and manufactures an optical breast imaging system to aid in the detection of breast cancer | Direttore/Membro del Consiglio | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 10 |
|---|---|
IBOD Imaging, Inc.
IBOD Imaging, Inc. Medical SpecialtiesHealth Technology Develops devices for diagnosing breast cancer | Health Technology |
Æterna Zentaris, Inc.
Æterna Zentaris, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products for diagnosis of adult growth hormone deficiency | Health Technology |
Ceapro, Inc.
Ceapro, Inc. BiotechnologyHealth Technology Develops and commercializes active ingredients and anti-aging products for for healthcare and cosmetic industries | Health Technology |
DOBI Medical Systems, Inc.
DOBI Medical Systems, Inc. Medical SpecialtiesHealth Technology Develops and manufactures an optical breast imaging system to aid in the detection of breast cancer | Health Technology |
The Courtagen Group LLC
The Courtagen Group LLC Investment ManagersFinance Acts as an alternative investment manager | Finance |
Harvard College
Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Pittsburgh School of Medicine
University of Pittsburgh School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Angiogenesis Foundation
The Angiogenesis Foundation Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit organization that engages in disrupting disease through angiogenesis | Commercial Services |
Leap Therapeutics, Inc.
Leap Therapeutics, Inc. BiotechnologyHealth Technology Engages in clinical stage immuno-oncology | Health Technology |
Medicenna Therapeutics Corp.
Medicenna Therapeutics Corp. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale